Adverse drug reactions (ADR) are important causes of deaths and hospitalization worldwide. ADR affects the patient’s compliance to treatments and may affect their trust in healthcare system. India has developed a platform for ADR monitoring & reporting since 1982, but despite of having wide population, the reporting rate of ADR’s is nowhere near to other small European countries.
Collection of adverse events helps to generate information regarding any new adverse event, its severity and frequency associated with a drug. This may further lead to change in the reference safety information (contraindications, warnings, and precautions, use in special population) and depending upon its risk-benefit analysis, may also be responsible for withdrawal of a drug from the market. Because of lack of the intention or awareness the stakeholders of medical field do not report ADR’s, that is why there are many drugs which are banned in other countries for their serious adverse effects but continue to be on the list of bestsellers in India.
Thus, it is extremely important to increase awareness among health-care professionals regarding diagnosis, prevention, and reporting of adverse drug events.
[googleapps domain=”drive” dir=”file/d/1POGfuNQ7InHWhsMJGj73EmfEE9Zd-3qz/preview” query=”” width=”640″ height=”480″ /]